YERXA BENJAMIN R 4
4 · Opus Genetics, Inc. · Filed Jul 27, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics (IRD) President Benjamin R. Yerxa Sells Shares
What Happened
Benjamin R. Yerxa, President and a director of Opus Genetics (IRD), reported a sale of 7,429 shares on 2026-07-23 at $2.97 per share, generating $22,064. This was a sale (code S) and not a buy—such sales are often routine rather than a directional signal.
Key Details
- Transaction date and price: 2026-07-23 — 7,429 shares @ $2.97 each (total ~$22,064).
- Shares owned after transaction: Not specified in the summary provided (not reported here).
- Footnote: The shares were sold automatically to satisfy tax withholding obligations arising from the vesting/settlement of restricted stock units (RSUs). This was an automatic, non‑discretionary sale.
- Filing timeliness: Form 4 filed 2026-07-27; this filing appears timely (within the standard two business‑day reporting window).
Context
This transaction reflects an automatic tax-withholding sale related to RSU vesting, per the filer’s footnote, not an active trading decision. For retail investors, purchases by insiders can be more informative about confidence in the company; routine withholding sales are common and typically do not indicate a change in insider sentiment.
Insider Transaction Report
Form 4
YERXA BENJAMIN R
DirectorPresident
Transactions
- Sale
Common Stock
[F1]2026-07-23$2.97/sh−7,429$22,064→ 704,106 total
Footnotes (1)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Signature
/s/ Amy Rabourn, by Power of Attorney|2026-07-27